Neuropeptide Y (NPY) RIA

pNeuropeptide Y (NPY) RIAbr /
img alt=For Research Use Only align=absMiddle src=http://www.alpco.com/img/ruo.gif / For Research Use Only/p
div class=prod_head_infohr /
/div
div class=prod_spec_box
div class=prod_specFormat:/div
div class=prod_spec_infoRadioimmunoassay/div
/div
div class=prod_spec_box
div class=prod_specSample Type:/div
div class=prod_spec_infoSerum, Plasma/div
/div
div class=prod_spec_box
div class=prod_specbSample Size:/b/div
div class=prod_spec_info200 micro;l/div
/div
div class=prod_spec_box
div class=prod_specbSize:/b/div
div class=prod_spec_info100 Tubes/div
/div
div class=prod_spec_box
div class=prod_specbRange:/b/div
div class=prod_spec_info9.4 - 300 pmol/L/div
/div
div class=prod_spec_box
div class=prod_specbSensitivity:/b/div
div class=prod_spec_info6 pmol/L/div
/div
div class=prod_spec_box
div class=prod_specbIncubation Time:/b/div
div class=prod_spec_info2 Days/div
div class=prod_spec_infonbsp;/div
/div
pbSummary:/b/p
pNeuropeptide Y RIA - The intended use of these reagents is for the assay of NPY in human Serum/Plasma by direct assay without extraction. NPY in the Serum/Plasma samples is assayed by a competitive radioimmunoassay using an antiSerum raised against synthetic NPY conjugated to bovine thyroglobulin. NPY in standards and samples compete with 125I-labeled NPY in binding to the antibodies. 125I-NPY binds in reverse proportion to the concentration of NPY in standardsand samples. Antibody-bound 125I-NPY is separated from the unbound fraction by using adouble antibody coupled to the solid phase. The radioactivity of the antibody-bound 125I-NPY is measured. The antiserum used in this method crossreacts less than 2.0% with human Peptide YY./p
pnbsp;/p
pnbsp;/p